SCHEMBL12747248

SCHEMBL12747248

Cc1cc(C)c2nc(-c3cc(C)nn3-c3ccccc3Cl)oc(=O)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ MAPK14 Q16539 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPK11 Q15759 1/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ C1R P00736 3/20 0.34
▸ ELANE P08246 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ PBRM1 Q86U86 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CDK4 P11802 1/20 0.32
▸ CCND1 P24385 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12911837 0.87 RXRA (0.46) MEN1KMT2APIK3CDPIK3CAPIK3CB
SCHEMBL12528160 0.85 RAB9A (0.35) SMN1; SMN2RAB9AMEN1KMT2APIK3CD
SCHEMBL12528298 0.85 RAB9A (0.46) SMN1; SMN2RAB9AKMT2AKDM4EALDH1A1
SCHEMBL4163531 0.82 ALDH1A1 (0.34) SMN1; SMN2MEN1KMT2AMAPK14KDM4E
SCHEMBL12528272 0.81 SMN1; SMN2 (0.39) SMN1; SMN2RAB9AMEN1KMT2APIK3CD
SCHEMBL951821 0.79 RXRA (0.46) ELANE
SCHEMBL5507360 0.78 CETP (0.35) MEN1KMT2AMAPK14KDM4EMAPK11
SCHEMBL12528235 0.78 DHODH (0.33) C1RALDH1A1PBRM1
SCHEMBL950938 0.77 CYP17A1 (0.34) SMN1; SMN2MEN1KMT2AC1RELANE
SCHEMBL12528553 0.75 DHODH (0.35) MEN1KMT2APIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071291-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME IKEGAMI HIROSHI 2011-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071291-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME ACHE, H1-2, H1-0 SMN1; SMN2 2851/4885RAB9A 391/4885MEN1 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback